- White directional arrow indicates tube direction
- Actual patient body contour displayed
- Sensor in tube’s distal tip displays tip position and indicates direction in real time with no lagging
ENvue Benefits
The ENvue technology is backed by clinical trials; usage in many hospitals in the US; FDA 510(k) cleared
1.) Patient
- Lower risk of lung placement
- Reduces the need for X-Ray, less radiation exposure
- Effective post pyloric feeding
- Shorten the time to initiate food delivery, reduce risk of malnutrition
2.) Staff
- Builds confidence when placing feeding tubes
- Supports accurate feeding tube insertions that avoid the lungs
- Enables post pyloric position to facilitate early enteral feeding in malnourished ICU patients
- Only one operator required
- Short learning curve, 24/7 customer support
3.) Hospital
- Reliable equipment that can be used across continuum of care
- Innovative approach to training builds staff confidence and acceptance
Surface Acoustic Wave (SAW) Technology: A Non-Invasive Revolution
While the ENvue System handles navigation, the company’s SAW technology platform addresses the aftermath of indwelling device use. UroShield and PainShield are not just accessories; they are disruptive therapeutic tools.
SAW technology creates low-frequency ultrasonic waves that run along the surface of a catheter or a patch on the skin. In the case of UroShield, these waves create an "acoustic shield" that prevents bacteria from adhering to the catheter surface.
This effectively stops the formation of biofilms, which are the primary cause of Catheter-Associated Urinary Tract Infections (CAUTIs). Clinical case series have shown a staggering 94% average reduction in CAUTIs and catheter blockages when using this technology.
Bridging the Gap: From Hospital to Home Care
The recent launch of over-the-counter (OTC) reusable ENFit syringes on January 14th, 2026, marks a strategic pivot toward the home heal-th-care sector. As hospital stays become shorter, the burden of care is shifting to the patient and their family.
These syringes comply with global ISO 80369-3 standards, ensuring they cannot be accidentally connected to the wrong medical lines, a critical safety feature in a home setting.
By offering these without a prescription, ENvue Medical, Inc. (Nasdaq: FEED) is tapping into a recurring revenue model that supports patient continuity of care outside the clinical environment.
Grab Report Sources And More Here: FEED Website. -----
And as we mentioned earlier, (Nasdaq: FEED) has multiple potential catalysts on our radar. Take a look:
#1. FEED Potential Catalyst - A Low Float May Help Establish An Environment For Heightened Volatility Potential.
According to info from the Yahoo Finance website, FEED has a low float.
The website reports this profile to have roughly 5.85Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility potential.
If the company provides positive news during the first half of 2026, could it help provide a breakout spark when paired with this volatility potential? -----
#2. FEED Potential Catalyst - A New Expansion Reflects Broad Clinical Applicability Of The ENvue Navigation Platform.
ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
Second ENvue Navigation Platform Deployed Within the Same Health System Reflects the Clinical Confidence in Company’s Real-Time Guided Feeding Tube Placement for Patients
TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical,” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that a major U.S. academic health network has expanded its use of the ENvue™ Navigation Platform into its American Burn Association-verified burn intensive care unit, marking the second deployment within the same health system and expanding access to ENvue’s technology for a particularly vulnerable patient population.
“We believe that this health network's decision to bring the ENvue Navigation Platform into their burn ICU speaks directly to the clinical versatility of our platform and institutional trust that we have earned with this network,” said Doron Besser, MD, Chief Executive Officer of ENvue Medical. “The clinical teams have successfully integrated our platform into their workflow, built confidence in its performance and are now expanding its use into a more complex and demanding care environment. We look forward to deepening our relationship with this health system and helping its clinicians to deliver the highest standard of care.”
...
“We are seeing growing demand from health systems looking to modernize feeding tube placement across their most complex care environments and make blind placement a thing of the past,” added Marc Waldman, Vice President of Commercial of ENvue Medical. “This expansion into a burn center reflects the broad clinical applicability of the ENvue platform, and we look forward to continuing to grow within this institution and others like it.”
...
Read the full article here. -----
#3. FEED Potential Catalyst - A Peer-Reviewed Study Validates The Potential Value Of Integrating The Company's Navigation Platform.
ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging
Validates Value of Integrating ENvue Navigation Platform as Standard of Care in U.S. Hospitals, Sa-ving Costs on Nursing Hours, Imaging, and Patient Complications
Findings Published in Official Journal of the American Association of Critical Care Nurses
TYLER, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that an independent, peer-reviewed study has been published in Critical Care Nurse – the official journal of the American Association of Critical Care Nurses – showing dramatic improvements in patient safety and operating cost reductions at Inova Health System, a five-hospital mid-Atlantic regional health system that adopted the ENvue™ Navigation Platform.
“This is a landmark study demonstrating how our real-time feeding tube guidance platform significantly improves safety and enables hospitals to function more efficiently to better service their patients,” said Doron Besser, MD, CEO of ENvue Medical. “Given the serious risks for both patients and hospitals, blind feeding tube placement is no longer acceptable as a standard of care. We believe data like this accelerates the clinical and institutional case for the adoption of ENvue’s platform and we expect it to directly support our commercialization efforts, driving the onboarding of new hospitals and expanding our commercial footprint across health systems nationwide.”
Titled “Dietitian-Led Feeding Tube Placement: Reducing Nursing Workload and Enhancing Patient Safety in the Intensive Care Unit,” the study tackles one of the most consequential procedural risks in hospital intensive care units: feeding tube misplacement. Feeding tubes are traditionally inserted blindly without real-time guidance, often leading to tubes accidentally entering the airway or lungs instead of the digestive tract. This can trigger ventilator-associated pneumonia (“VAP”), a serious and potentially fatal lung infection. Highlighted in the study, by using ENvue’s navigation technology, Inova reduced VAP cases by 67 percent and eliminated accidental insertions of feeding tubes into patients’ lungs across 531 consecutive placements in its first year of use. According to studies published in ePlasty and Medicine, inadvertent airway placement rates are estimated at 1.2 to 3.2 percent when using blind placement techniques. Additionally, based on Agency for Heal-thcare Research and Quality (AHRQ) benchmarks, ENvue estimates that the reduction in VAP cases avoided over $1.5Mn in hospital costs in year one.
...
Read the full article here. -----
#4. FEED Potential Catalyst - A 6-Month Chart History Depicts Explosive Behavior Over Short Term Periods.
Take a look at FEED's 6-Month chart: |
0 التعليقات:
إرسال تعليق